Cargando…
Abstract QS22: Defining Enhanced Recovery Pathway With Or Without Liposomal Bupivacaine In Diep Flap Breast Reconstruction
Autores principales: | Garza, Ricardo, Boyle, Carolyn E., Liu, Yulun, Kadakia, Yash, Cooper, Julie L., Khan, Sami U., Haddock, Nicholas T., Teotia, Sumeet S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224885/ http://dx.doi.org/10.1097/01.GOX.0000667944.75272.a8 |
Ejemplares similares
-
Abstract QS14: Abdominal Weakness, Bulge Or Hernia After DIEP Flaps: An Algorithm Of Management, Prevention, And Surgical Repair With Classification
por: Warren, Abby, et al.
Publicado: (2020) -
Abstract 67: Patient Selection For DIEP Flap Breast Reconstruction In The Obese Population: Stratifying Surgical Risk Factors For Patient Inclusion Or Exclusion
por: Jayaraman, Avinash P., et al.
Publicado: (2020) -
Abstract 76: Implications Of Instituting An Eras Pathway In Patients Receiving Chemotherapy In Microsurgical Breast Reconstruction
por: Garza, Ricardo, et al.
Publicado: (2020) -
Abstract 21: Optimizing Perforator Selection: A Comprehensive, Multivariate Analysis of Fat Necrosis and Abdominal Morbidity in DIEP Flap Breast Reconstruction
por: Hembd, Austin S., et al.
Publicado: (2018) -
Abstract 146: Preoperative CTA Efficiently Facilitates Perforator Decision-Making in DIEP Flap Breast Reconstruction: a Blinded Prospective Study
por: Dumestre, Danielle O., et al.
Publicado: (2019)